Sodium Channel Blockers: The Non-Opioid Pain Revolution After Vertex's Journavx

TherapueticsMedical ResearchersClinical Trials
Written By Corey Hubbard

Glassbury Cares Podcast

Sodium Channel Blockers: The Non-Opioid Pain Revolution After Vertex's Journavx
Glassbury Team

Episode #18

Corey Hubbard
Previous

Revolutionizing Global Health: WHO's Bold Plan for Fairer, More Inclusive Clinical Trials
Next

BioAtla's BA3182 Shows Promising Safety and Anti-Tumour Activity in Metastatic Adenocarcinoma